Niki BioSolutions, Inc.

Healthcare · Biotechnology · United States

Last price 1.77 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.20M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium ...